Clinical Trials
2 trialsNCT07620041 2026-06-02
QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction
Qilu Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT01634893 2016-03-25
Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
The University of Texas Health Science Center at San Antonio
Phase 1 Completed